Press Releases
Fortress Biotech: Very Complicated, Considerably Undervalued

, 12 December 2018 -- Fortress Biotech has established nine subsidiary companies because 2013, each financed differently and every focused on an area of unmet will need. Fortress CEO and longtime life sciences investor Lindsay Rosenwald lays out his ambitious plans for the future.

Fortress Biotech is really a biopharmaceutical company committed to acquiring, establishing and commercializing novel pharmaceutical and biotechnology products. Get additional details about Fortress Bio

Company assets include things like interests in ten biotech companies, three of that are publicly listed, a publicly listed, full-service investment bank, and a particular goal acquisition company ("SPAC").

Due to the fact 5 portfolio companies are publicly listed, we can calculate the worth of its public portfolio, which in return makes it possible for us to calculate the market-implied value of the private portfolio.

The private portfolio, on the other hand, seems to become undervalued offered the expectable market capitalization on the IPO of subsidiary Caelum Biosciences.

I would like to present you with my evaluation of a company that I've been intrigued by ever due to the fact it came up on one of my biotech stock screeners, since it is definitely unlike something else it is possible to obtain inside the public biotech markets.

It truly is not one, but ten biotech companies bundled into one, with a pretty broad pipeline of drugs, ranging from pre-clinical to late-stage. It also contains interests in a full-service investment bank in addition to a specific purpose acquisition company ("SPAC"). Though a majority of its subsidiaries are nevertheless private and present limited financial facts, we are able to effortlessly assess the value of its public portfolio, and use it to make an estimate with the private portfolio's value. For the advantage of an investor, the company will not only provide catalysts via its pipeline, but in addition via the planned initial public providing of a subsidiary within the subsequent months. This highly intriguing company is called Fortress Biotech (NASDAQ:FBIO).

Company Description and History
Fortress Biotech, in its personal words, is usually a "biopharmaceutical company devoted to acquiring, creating and commercializing novel pharmaceutical and biotechnology products."

Fortress Biotech's story originally started in 2006 when the company was nevertheless named Coronado Biosciences. It was in stealth mode until 2011, when it announced that it had raised virtually USD 50mn. in two separate funding rounds. The company shortly following announced that it would go public by registering its private shares as widespread stock. Most interestingly, at the time, Coronado's principal item was a drug derived from a parasite discovered in pigs, with trials for any quantity of indications including Crohn's disease and autism. Nonetheless, the trial for Crohn's illness was discontinued immediately after assessment from an independent advisory committee, plus the study investigating the effect on the drug in ###### with Autism Spectrum Disorder also failed to attain statistic significance.

# # #

Submitted by Kyle Crum on Wednesday, 12 December 2018 at 12:59 AM
Category: Business
Related News

The Benefits of Using an Online Dispensary
Wednesday, 20 Mar 2019

Toronto Pool Supplies LED lights cuts expenses at Toronto Swimming Pool
Wednesday, 20 Mar 2019

Online Purchasing Producing Your Life Easy
Wednesday, 20 Mar 2019

Bridesmaid Dresses to Pair With Red Wedding Gown
Wednesday, 20 Mar 2019

Asthma Therapeutics Market Is Expected To Reach USD 23.4 Bn By 2024: Credence Research
Wednesday, 20 Mar 2019

Related Events

Credit Week 2019, London
Tuesday, 19 Mar 2019

EG Media Tech
Tuesday, 19 Mar 2019

Choose the Best Industrial Construction Company in Amarillo TX
Tuesday, 19 Mar 2019

SPE Workshop: Innovative Arctic Technologies | 2019 | Harstad, Norway
Wednesday, 20 Mar 2019

Chief Customer Officer Melbourne Conference 2019
Wednesday, 20 Mar 2019

Latest News

The Benefits of Using an Online Dispensary
Wednesday, 20 Mar 2019

Food Stabilizer Market: Changing Lifestyles Demand Quality Foods, Boost Market’s Expansion
Wednesday, 20 Mar 2019

Toronto Pool Supplies LED lights cuts expenses at Toronto Swimming Pool
Wednesday, 20 Mar 2019

Cooking Oils & Fats Market: Growing Demand for High Quality Edible Oils & Fats to Fuel Market
Wednesday, 20 Mar 2019

Online Purchasing Producing Your Life Easy
Wednesday, 20 Mar 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 20 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • World Pharma Pricing and Market Access Congress 2019
  • Innate Killer Summit 2019
  • Credit Week 2019, London
  • Middle East Pharmaceutical Cold Chain Conference
  • ICO-IO Combinations Summit 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.